Smooth muscle myosin heavy chain and caldesmon expression in the anterior vaginal wall of women with and without pelvic organ prolapse

Muriel K. Boreham, Rodney T. Miller, Joseph I. Schaffer, R. Ann Word

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

OBJECTIVE: The aim of this study was to quantify the expression of smooth muscle myosin heavy chain (SM-MHC) and caldesmon in the anterior vaginal wall of women with and without pelvic organ prolapse. STUDY DESIGN: Immunoblot analysis was conducted on protein extracts from the vaginal muscularis of 15 women with and 11 women without pelvic organ prolapse by using specific antibodies for SM-MHC, nonmuscle MHC-B, and caldesmon. The fraction of muscularis containing smooth muscle was determined by morphometric analysis of histologic cross sections. Reverse transcriptase-polymerase chain reaction was used to amplify SM-MHC isoforms produced by alternative splicing in the myosin head. RESULTS: Whereas the expression of SM-MHC was increased modestly (2-fold), expression of smooth muscle caldesmon was increased 6- to 7-fold in vaginal muscularis from women with prolapse. The relative distribution of SM-MHC isoforms was similar in both groups. CONCLUSIONS: Caldesmon is increased substantially in vaginal smooth muscle of women with pelvic organ prolapse. Caldesmon inhibits actin-activated myosin magnesium adenosine triphosphatase activity and inhibits the maintenance of contractile force. Thus, this disproportionate increase in caldesmon, relative to myosin, may result in inhibition of vaginal smooth muscle contractility and force maintenance.

Original languageEnglish (US)
Pages (from-to)944-952
Number of pages9
JournalAmerican Journal of Obstetrics and Gynecology
Volume185
Issue number4
DOIs
StatePublished - 2001

Fingerprint

Smooth Muscle Myosins
Calmodulin-Binding Proteins
Pelvic Organ Prolapse
Myosin Heavy Chains
Smooth Muscle
Myosins
Protein Isoforms
Maintenance
Ca(2+) Mg(2+)-ATPase
Prolapse
Alternative Splicing
Reverse Transcriptase Polymerase Chain Reaction
Actins
Antibodies

Keywords

  • Contractile proteins
  • Cystocele
  • Immunohistochemistry
  • Isoform
  • Morphometry

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

@article{d57a605a37b347a598944bcf1ed3119e,
title = "Smooth muscle myosin heavy chain and caldesmon expression in the anterior vaginal wall of women with and without pelvic organ prolapse",
abstract = "OBJECTIVE: The aim of this study was to quantify the expression of smooth muscle myosin heavy chain (SM-MHC) and caldesmon in the anterior vaginal wall of women with and without pelvic organ prolapse. STUDY DESIGN: Immunoblot analysis was conducted on protein extracts from the vaginal muscularis of 15 women with and 11 women without pelvic organ prolapse by using specific antibodies for SM-MHC, nonmuscle MHC-B, and caldesmon. The fraction of muscularis containing smooth muscle was determined by morphometric analysis of histologic cross sections. Reverse transcriptase-polymerase chain reaction was used to amplify SM-MHC isoforms produced by alternative splicing in the myosin head. RESULTS: Whereas the expression of SM-MHC was increased modestly (2-fold), expression of smooth muscle caldesmon was increased 6- to 7-fold in vaginal muscularis from women with prolapse. The relative distribution of SM-MHC isoforms was similar in both groups. CONCLUSIONS: Caldesmon is increased substantially in vaginal smooth muscle of women with pelvic organ prolapse. Caldesmon inhibits actin-activated myosin magnesium adenosine triphosphatase activity and inhibits the maintenance of contractile force. Thus, this disproportionate increase in caldesmon, relative to myosin, may result in inhibition of vaginal smooth muscle contractility and force maintenance.",
keywords = "Contractile proteins, Cystocele, Immunohistochemistry, Isoform, Morphometry",
author = "Boreham, {Muriel K.} and Miller, {Rodney T.} and Schaffer, {Joseph I.} and Word, {R. Ann}",
year = "2001",
doi = "10.1067/mob.2001.117342",
language = "English (US)",
volume = "185",
pages = "944--952",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Smooth muscle myosin heavy chain and caldesmon expression in the anterior vaginal wall of women with and without pelvic organ prolapse

AU - Boreham, Muriel K.

AU - Miller, Rodney T.

AU - Schaffer, Joseph I.

AU - Word, R. Ann

PY - 2001

Y1 - 2001

N2 - OBJECTIVE: The aim of this study was to quantify the expression of smooth muscle myosin heavy chain (SM-MHC) and caldesmon in the anterior vaginal wall of women with and without pelvic organ prolapse. STUDY DESIGN: Immunoblot analysis was conducted on protein extracts from the vaginal muscularis of 15 women with and 11 women without pelvic organ prolapse by using specific antibodies for SM-MHC, nonmuscle MHC-B, and caldesmon. The fraction of muscularis containing smooth muscle was determined by morphometric analysis of histologic cross sections. Reverse transcriptase-polymerase chain reaction was used to amplify SM-MHC isoforms produced by alternative splicing in the myosin head. RESULTS: Whereas the expression of SM-MHC was increased modestly (2-fold), expression of smooth muscle caldesmon was increased 6- to 7-fold in vaginal muscularis from women with prolapse. The relative distribution of SM-MHC isoforms was similar in both groups. CONCLUSIONS: Caldesmon is increased substantially in vaginal smooth muscle of women with pelvic organ prolapse. Caldesmon inhibits actin-activated myosin magnesium adenosine triphosphatase activity and inhibits the maintenance of contractile force. Thus, this disproportionate increase in caldesmon, relative to myosin, may result in inhibition of vaginal smooth muscle contractility and force maintenance.

AB - OBJECTIVE: The aim of this study was to quantify the expression of smooth muscle myosin heavy chain (SM-MHC) and caldesmon in the anterior vaginal wall of women with and without pelvic organ prolapse. STUDY DESIGN: Immunoblot analysis was conducted on protein extracts from the vaginal muscularis of 15 women with and 11 women without pelvic organ prolapse by using specific antibodies for SM-MHC, nonmuscle MHC-B, and caldesmon. The fraction of muscularis containing smooth muscle was determined by morphometric analysis of histologic cross sections. Reverse transcriptase-polymerase chain reaction was used to amplify SM-MHC isoforms produced by alternative splicing in the myosin head. RESULTS: Whereas the expression of SM-MHC was increased modestly (2-fold), expression of smooth muscle caldesmon was increased 6- to 7-fold in vaginal muscularis from women with prolapse. The relative distribution of SM-MHC isoforms was similar in both groups. CONCLUSIONS: Caldesmon is increased substantially in vaginal smooth muscle of women with pelvic organ prolapse. Caldesmon inhibits actin-activated myosin magnesium adenosine triphosphatase activity and inhibits the maintenance of contractile force. Thus, this disproportionate increase in caldesmon, relative to myosin, may result in inhibition of vaginal smooth muscle contractility and force maintenance.

KW - Contractile proteins

KW - Cystocele

KW - Immunohistochemistry

KW - Isoform

KW - Morphometry

UR - http://www.scopus.com/inward/record.url?scp=0034780607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034780607&partnerID=8YFLogxK

U2 - 10.1067/mob.2001.117342

DO - 10.1067/mob.2001.117342

M3 - Article

C2 - 11641683

AN - SCOPUS:0034780607

VL - 185

SP - 944

EP - 952

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 4

ER -